Annals of Oncology Annals of Oncology, Elsevier, 2017, Annals of oncology, 28, pp.2169-2178. ⟨10.1093/annonc/mdx289⟩ Dreyling, M, Morschhauser, F, Bouabdallah, K, Bron, D, Cunningham, D, Assouline, S E, Verhoef, G, Linton, K, Thieblemont, C, Vitolo, U, Hiemeyer, F, Giurescu, M, Garcia-Vargas, J, Gorbatchevsky, I, Liu, L, Koechert, K, Peña, C, Neves, M, Childs, B H & Zinzani, P L 2017, ' Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma ', Annals of Oncology, vol. 28, no. 9, pp. 2169-2178 . https://doi.org/10.1093/annonc/mdx289, https://doi.org/10.1093/annonc/mdx289 Annals of Oncology, 2017, Annals of oncology, 28, pp.2169-2178. ⟨10.1093/annonc/mdx289⟩ Annals of oncology, 28 (9